Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 28, 2017; 23(4): 653-660
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.653
Table 1 Patient characteristics, etiology of liver cirrhosis, Child-Pugh class, and post-operative parameters grouped for laparoscopic procedure n (%)
VariablesLLRLRFAP value
(n = 24)(n = 22)
Patient-related characteristics
Sex (F/M)8/164/18NS
Age (yr)63.58 ± 9.5560.82 ± 7.25NS
Etiology of liver cirrhosis
HCV-related11 (45.8)8 (36.4)NS
HBV-related6 (25)8 (36.4)NS
Alcoholic6 (25)3 (13.6)NS
Mixte1 (4.2)0 (0)NS
Other0 (0)2 (9.1)NS
Child-Pugh class
Child A22 (91.7)12 (54.5)0.007
Child B2 (8.3)6 (27.3)NS
Child C0 (0)2 (9.1)NS
Unknown0 (0)2 (9.1)NS
Post-operative parameters
Single tumour20 (83.3)6 (27.3)< 0.001
Multiple tumours4 (16.6)16 (72.7)< 0.001
Treated nodules/patient1.41 ± 0.772.72 ± 1.54< 0.001
Tumour diameter (mm)33.0 ± 13.8326.25 ± 13.13NS
Follow-up (mo)44.74 ± 21.3040.27 ± 30.89NS
Intrahepatic recurrence16 (66.7)15 (68.2)NS
Local recurrence5 (20.9)8 (36.4)NS
Recurrence IT (mo)25.53 ± 19.1122.88 ± 30.62NS
Table 2 Cox proportional hazard regression for overall survival and disease-free survival
VariablesβHR (95%CI)P value
Overall survival
Treatment (LRFA)0.8122.252 (0.983-5.156)NS
Sex (Male)0.0731.076 (0.426-2.717)NS
Age0.0081.008 (0.961-1.059)NS
Diagnosis (HCV)0.8282.288 (0.624-8.382)NS
Preop TACE (Yes)0.5001.649 (0.737-3.689)NS
No. intraop. nodules0.8002.225 (1.594-3.108)< 0.001
Local recurrence (Yes)-0.0140.985 (0.414-2.345)NS
Dist. recurrence (Yes)1.5434.680 (0.618-35.440)NS
Disease-free survival
Treatment (LRFA)0.4641.590 (0.771-3.282)NS
Sex (Male)0.5871.798 (0.732-4.422)NS
Age-0.0190.980 (0.939-1.024)NS
Diagnosis (HCV)-0.3000.740 (0.275-1.993)NS
Preop TACE (Yes)0.1251.133 (0.549-2.340)NS
No. intraop. nodules0.2161.241 (0.946-1.628)NS